GlassScriptPhysician profile
Kimberly A Johnson
NPI 1477024370
$3,337.22
in general payments reported to CMS, 2019-2025
10 companies · $271 in 2025
The $271 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $958 · 2022: $1,329 · 2023: $405 · 2024: $374 · 2025: $271.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,050.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,050.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $1,442.69 | 2021-2025 | Biomonitor, Acticor 7 Vr-T Dx, Amvia Edge |
| Boston Scientific Corporation | $1,029.04 | 2021-2025 | Farapulse, Watchman Flx |
| Abbott Laboratories | $275.84 | 2022-2025 | Aveir, Diamondback Peripheral, Thoratec Heartmate 3 Lvas Implant Kit |
| Astellas Pharma US INC | $222.30 | 2021-2022 | |
| Novo Nordisk INC | $162.08 | 2024 | |
| Akebia Therapeutics INC | $104.92 | 2024 | |
| Edwards Lifesciences Corporation | $36.63 | 2025 | Evoque |
| Tactile Systems Technology INC | $25.42 | 2023 | Entre Plus, Flexitouch Plus |
| Amgen INC. | $20.53 | 2024 | Repatha |
| Novartis Pharmaceuticals Corporation | $17.77 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kimberly Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.